Equites Radar

HSIC · Henry Schein, Inc.

Medical DistributionUnited StatesAnalyst view: none

$85.47

+1.30% last session

End-of-day data · updated 2026-07-28

Bullish4 bullish · 1 bearish technical signals
To mean target: +3.5%

Market cap

$10B

Enterprise value

$15B

Trailing P/E

25.6

Forward P/E

14.3

Dividend yield

Beta

0.81

Avg volume

2M

Employees

25K

2D change

5D change

0.09%

10D change

-3.66%

30D change

-0.40%

60D change

10.49%

MTD change

0.11%

YTD change

11.95%

Analyst Outlook

Consensus rating
Recommendation mean (1–5)
Covering analysts16
Mean price target$88.50
Low price target$64.00
Upside to mean target+3.5%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)56.9
50-day MA$80.77
200-day MA$75.84
Price vs 50-day MA+6.1%
Price vs 200-day MA+13.0%
MACD histogram-0.46
Volume vs 3-month avg0.8×
52w low $62.0352w high $88.26

Analyst sentiment over time — HSIC

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-28

Latest call per bank · past 12 months

UBS

Neutral

$89.00

+4.1% vs price
▲ raised from $85.00Maintains · 2026-07-28

Morgan Stanley

Underweight

$64.00

-25.1% vs price
▲ raised from $61.00Maintains · 2026-04-24

Citigroup

Buy

$100

+17.0% vs price
▲ raised from $0.00Initiates · 2026-04-15

JP Morgan

Overweight

$92.00

+7.6% vs price
▲ raised from $78.00Maintains · 2026-02-25

Wells Fargo

Equal-Weight

$87.00

+1.8% vs price
▲ raised from $76.00Maintains · 2026-02-25

Barclays

Overweight

$86.00

+0.6% vs price
▲ raised from $0.00Initiates · 2025-12-09

Recent rating actions

DateFirmActionRatingPrice target
2026-07-28UBSMaintainsNeutral$85.00 $89.00
2026-07-09BMO CapitalInitiatesMarket Perform$0.00 $85.00
2026-06-11BTIGUpgradeNeutralBuy$0.00 $100
2026-05-06UBSMaintainsNeutral$87.00 $85.00
2026-05-06MizuhoMaintainsNeutral$88.00 $82.00
2026-04-24Morgan StanleyMaintainsUnderweight$61.00 $64.00
2026-04-16BTIGInitiatesNeutral$0.00
2026-04-15CitigroupInitiatesBuy$0.00 $100

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 57 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 6.1% above the 50-day MA ($80.77).
  • Price vs 200-day MA: Trading 13.0% above the 200-day MA ($75.84).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.46) — short-term momentum is fading.
  • 52-week range: Price is within 5% of the 52-week high ($88.26).

HSIC Price Chart

Loading chart for HSIC

Fundamentals

Revenue (TTM)$13B
EBITDA$1.0B
Free cash flow$0M
Operating cash flow$1.0B
Book value / share$28.54
Net debt / EBITDA3.5
WACC9.0%
Revenue growth6.00%
Earnings growth4.00%

About Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

More in Medical Distribution

Screen HSIC against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.